ICD-10-CM Code C43.60

Malignant melanoma of unspecified upper limb, including shoulder

Version 2021 Billable Code

Valid for Submission

C43.60 is a billable code used to specify a medical diagnosis of malignant melanoma of unspecified upper limb, including shoulder. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code C43.60 might also be used to specify conditions or terms like malignant melanoma of axilla, malignant melanoma of finger, malignant melanoma of forearm, malignant melanoma of hand, malignant melanoma of hand, malignant melanoma of shoulder, etc

ICD-10:C43.60
Short Description:Malignant melanoma of unsp upper limb, including shoulder
Long Description:Malignant melanoma of unspecified upper limb, including shoulder

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Malignant melanoma of axilla
  • Malignant melanoma of finger
  • Malignant melanoma of forearm
  • Malignant melanoma of hand
  • Malignant melanoma of hand
  • Malignant melanoma of shoulder
  • Malignant melanoma of skin of axilla
  • Malignant melanoma of skin of elbow
  • Malignant melanoma of skin of finger
  • Malignant melanoma of skin of forearm
  • Malignant melanoma of skin of hand
  • Malignant melanoma of skin of shoulder
  • Malignant melanoma of skin of upper arm
  • Malignant melanoma of skin of upper limb
  • Malignant melanoma of skin of wrist
  • Malignant melanoma of upper arm
  • Malignant melanoma of upper limb
  • Malignant neoplasm of skin of forearm
  • Malignant neoplasm of skin of upper arm
  • Neoplasm of skin of axilla
  • Neoplasm of skin of elbow
  • Neoplasm of skin of finger
  • Neoplasm of skin of forearm
  • Neoplasm of skin of shoulder
  • Neoplasm of skin of upper arm
  • Neoplasm of skin of wrist

Diagnostic Related Groups

The ICD-10 code C43.60 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2021.

  • 595 - MAJOR SKIN DISORDERS WITH MCC
  • 596 - MAJOR SKIN DISORDERS WITHOUT MCC

Convert C43.60 to ICD-9

  • 172.6 - Malig melanoma arm (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • Melanoma and other malignant neoplasms of skin (C43-C44)
      • Malignant melanoma of skin (C43)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Information for Patients


Melanoma

Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or "ugly looking."

Thinking of "ABCDE" can help you remember what to watch for:

  • Asymmetry - the shape of one half does not match the other
  • Border - the edges are ragged, blurred or irregular
  • Color - the color is uneven and may include shades of black, brown and tan
  • Diameter - there is a change in size, usually an increase
  • Evolving - the mole has changed over the past few weeks or months

Surgery is the first treatment of all stages of melanoma. Other treatments include chemotherapy and radiation, biologic, and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute

  • After chemotherapy - discharge (Medical Encyclopedia)
  • Melanoma (Medical Encyclopedia)
  • Melanoma of the eye (Medical Encyclopedia)

[Learn More]